Evidence map›Paper›PMID 39833739›Full record

ArticleBMC infectious diseases2025

Recurrent NTM pulmonary disease despite avoidance of hot spring exposure in a plaque psoriasis patient treated with Secukinumab: a case report.

Yixiao Wei, Chunlei Wang, Lingtao Chong, Xiaojing Cui

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yixiao Wei *Peking University Health Science Center, Beijing, 100191, China.
Chunlei Wang *Laboratory of Clinical Microbiology and Infectious Diseases, China-Japan Friendship Hospital, Beijing, 100029, China.
Lingtao ChongFuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.
Xiaojing CuiNational Clinical Research Center of Respiratory Diseases, Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, 100029, China. cuixiaojing86@163.com.

Funding

National High Level Hospital Clinical Research Funding, Elite Medical Professionals Project of China-Japan Friendship Hospital 2022-NHLHCRF-YS-02
6 · The paper itself

Abstract

backgroundRecurrent Non-Tuberculous Mycobacterial Pulmonary Disease (NTM-PD) related to treatment with Secukinumab has not been previously documented. CASE PRESENTATION: Despite adherence to treatment and avoiding hot springs, a plaque psoriasis patient experienced persistent NTM-PD relapses.

conclusionsThere is potential association between Secukinumab, an IL-17A inhibitor, and NTM disease, echoing anti-TNF biologics' NTM risk, indicating the urgent need for further research on pathogenic mechanisms and risk factors.

Indexed as

Antibodies, Monoclonal, HumanizedMycobacterium Infections, NontuberculousPsoriasisHot SpringsHumansRecurrenceAntibodies, Monoclonal, HumanizedsecukinumabMycobacterium avium complexNontuberculous mycobacteriaNTM-PDPsoriasisSecukinumab

Identifiers

PMID39833739
PMCPMC11744850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.